<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01790256</url>
  </required_header>
  <id_info>
    <org_study_id>Cereve CIP-003</org_study_id>
    <nct_id>NCT01790256</nct_id>
  </id_info>
  <brief_title>Comparison of Two Temperatures to Treat Insomnia</brief_title>
  <official_title>A Multi-center Prospective, Blinded, Randomized Crossover Study to Compare the CerÃªve Sleep System at Two Different Temperatures in Primary Insomnia Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cereve, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cereve, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insomnia patients demonstrate subjective and physiological hyperarousal. The Cereve Sleep
      System has been proposed as a clinical treatment to reverse this hyperarousal in insomnia
      patients. The current study is a two dose study to determine the optimal temperature for the
      Cereve Sleep System. Primary outcome measures include EEG sleep measured sleep latency and
      sleep efficiency.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Polysomnographically determined sleep latency as changed from baseline measures</measure>
    <time_frame>1-2 weeks</time_frame>
    <description>Polysomnographically determined sleep parameters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Poloysomnographically determined sleep efficiency as changed from baseline measures</measure>
    <time_frame>1-2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Primary Insomnia</condition>
  <arm_group>
    <arm_group_label>Cereve Sleep System at 14-16 degrees C.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cereve Sleep System at 30 degrees C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cereve Sleep System at 30 degrees C</intervention_name>
    <arm_group_label>Cereve Sleep System at 30 degrees C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cereve Sleep System at 14-16 degrees C</intervention_name>
    <arm_group_label>Cereve Sleep System at 14-16 degrees C.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age &gt;/= 22

        Diagnosis of insomnia that meets criteria for DSM IV diagnosis of primary insomnia and
        International Classification of Sleep Disorders (ICSD)general insomnia criteria and RDC
        insomnia disorder criteria

        Subjects must remain alcohol-free and avoid drugs that could affect sleep during the study.

        &gt;14 on the Insomnia Severity Index

        Sleep -Wake diaries demonstrate sleep efficiency &lt;85% on at least 50% of nights

        Exclusion Criteria:

        Neuropsychiatric disorders that may independently affect sleep, brain function or
        cognition, such as current major syndromal psychiatric disorders, including DSM-IV mood,
        anxiety, psychotic, and substance use disorders.

        Specific exclusionary diagnoses include major depressive disorder, dysthymic disorder,
        bipolar disorder, panic disorder, obsessive compulsive disorder, generalized anxiety
        disorder, any psychotic disorder, and any current substance use disorder.

        Unstable medical conditions Raynaud's Disease

        Irregular sleep schedules including shift workers;

        A latency to persistent sleep &lt; 15 on either the sleep disorder screening night or the
        baseline PSG sleep night;

        A sleep efficiency &gt; 85% on either the sleep disorder screening night or the baseline PSG
        sleep night;

        An AHI (apnea hypopnea index) &gt; 10 and/or a periodic limb movement arousal index (PLMAI) &gt;
        15 from SN1

        Body Mass Index &gt;34

        Use of medications known to affect sleep or wake function

        Consumption of more than one alcoholic drink per day, or more than 7 drinks per week prior
        to study entry.

        Caffeinated beverages &gt; 4/day or the equivalent of more than 4 cups of coffee Unable to
        read or understand English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Lankford, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleep Center of Georgia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Russell Rosenberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NeuroTrials</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leon Rosenthal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleep Medicine Associates of Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Mayleben, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Community Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Wylie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Preferred Research Partners</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Muehlbach, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clayton Sleep Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Seiden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Broward Research Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timothy Grant, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Miami Research Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil Feldman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Group of St. Petersburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Paul Wylie</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Timothy Grant</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David Seiden</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neil Feldman</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <zip>33707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alan Lankford</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russell Rosenberg</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David Mayleben</name>
      <address>
        <city>Crestview Hills</city>
        <state>Kentucky</state>
        <zip>41047</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mark Muehlbach</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leon Rosenthal</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2013</study_first_submitted>
  <study_first_submitted_qc>February 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2013</study_first_posted>
  <disposition_first_submitted>February 2, 2015</disposition_first_submitted>
  <disposition_first_submitted_qc>May 5, 2015</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">May 22, 2015</disposition_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

